Neuroendocrine phenotype as an acquired resistance mechanism in ALK-rearranged lung adenocarcinoma. [electronic resource]
Producer: 20161114Description: 15-8 p. digitalISSN:- 1872-8332
- Adenocarcinoma -- drug therapy
- Adenocarcinoma of Lung
- Anaplastic Lymphoma Kinase
- Clavicle -- pathology
- Crizotinib
- Drug Resistance, Neoplasm
- Female
- Gene Rearrangement
- Humans
- Lung Neoplasms -- drug therapy
- Middle Aged
- Neuroendocrine Tumors -- pathology
- Protein Kinase Inhibitors -- therapeutic use
- Pyrazoles -- therapeutic use
- Pyridines -- therapeutic use
- Receptor Protein-Tyrosine Kinases -- genetics
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.